Dr. Reddy's Sued In U.S. Court By AbbVie For Zemplar Patent Infringement
This article was originally published in PharmAsia News
Executive Summary
AbbVie has sued Dr. Reddy's Laboratories in a U.S. court for patent infringement of its Zemplar (parecalcitol) for treating hyper-parathyroidism associated with renal failure.